//
Rebecca Ann C Auer - American Society of Clinical Oncology (ASCO) , 2022
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
Tinzaparin
Ruinuo Jia - American Society of Clinical Oncology (ASCO) , 2022
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
Megestrol acetate
Anthony B. El-Khoueiry - American Society of Clinical Oncology (ASCO) , 2022
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
Pembrolizumab
Nishanth Thalambedu - American Society of Clinical Oncology (ASCO) , 2022
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
N/A
Sarah E. Detlefs - Society for Maternal-Fetal Medicine (SMFM) , 2022
Therapeutic Area
Disease
Drug/Treatment
Blood/haematological Diseases
Venous thrombosis
N/A
Satish Maharaj - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
N/A
Upama Giri - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
Pembrolizumab
Luca Moscetti - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
Abemaciclib
Christine G. Kohn - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
rivaroxaban
Andres J. Muoz Martn - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
apixaban
Aneesha Ananthula - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
Pembrolizumab
Ellen Marcus - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
Albert
Yukari Tsubata - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
Edoxaban
Christos Fountzilas - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
N/A
Cinduja Nathan - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
N/A
Ayse Ece Cali Daylan - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
N/A
Helene Doubre - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
N/A
Aneesha Ananthula - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
N/A
Vincenza Conteduca - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
Enzalutamide
Anglique DA Silva - American Society of Clinical Oncology (ASCO) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Venous thrombosis
Lenalidomide